Skip to main content
OpenTrials

Clinical trial condition

Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])

Explore clinical trials studying Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ]). Study availability and eligibility vary by location and protocol.

3 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ]) trial results

Recruiting

Neoadjuvant Cadonilimab Combined With Perioperative Oxaliplatin Plus S1 for Diffuse or Mixed Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

NCT06949033

Conditions
Adjuvant Chemotherapy, Digestive System Diseases, Digestive System Neoplasms, +11 more
Locations
  • Gansu Provincial Hospital Lanzhou, Gansu, China
  • Lanzhou University Second Hospital Lanzhou, Gansu, China
  • The First Hospital of Lanzhou University Lanzhou, Gansu, China
  • The Gastrointestinal Surgery Department, Sun Yat-sen University Cancer Center Gansu Hospital Lanzhou, Gansu, China
View Trial Details
Recruiting

Neoadjuvant Apatinib Combined With Sintilimab and Perioperative SOX Versus Neoadjuvant Sintilimab Combined With Perioperative SOX for Intestinal Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

NCT06925243

Conditions
Adjuvant Chemotherapy, Digestive System Diseases, Digestive System Neoplasms, +11 more
Locations
  • First Hospital of Lanzhou University Lanzhou, Gansu, China
  • Gansu Provincial Hospital Lanzhou, Gansu, China
  • Lanzhou University Second Hospital Lanzhou, Gansu, China
  • The Gastrointestinal Surgery Department, Sun Yat-sen University Cancer Center Gansu Hospital Lanzhou, Gansu, China
View Trial Details
Completed

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

NCT03538028

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +105 more
Locations
  • The Angeles Clinic and Research Center Los Angeles, California, United States
  • Hackensack Medical Center Hackensack, New Jersey, United States
  • Carolina BioOncology Institute Huntersville, North Carolina, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
View Trial Details

Related conditions